Cargando…
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model
Clinical use of neurotoxins from Clostridium botulinum is well established and is continuously expanding, including in treatment of pain conditions. Background: The serotype A (BoNT/A) has been widely investigated, and current data demonstrate that it induces analgesia and modulates nociceptive proc...
Autores principales: | Finocchiaro, Alba, Marinelli, Sara, De Angelis, Federica, Vacca, Valentina, Luvisetto, Siro, Pavone, Flaminia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869416/ https://www.ncbi.nlm.nih.gov/pubmed/29562640 http://dx.doi.org/10.3390/toxins10030128 |
Ejemplares similares
-
Xeomin(®), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury
por: Mastrorilli, Valentina, et al.
Publicado: (2023) -
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes
por: Marinelli, Sara, et al.
Publicado: (2012) -
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice
por: Vacca, Valentina, et al.
Publicado: (2020) -
Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders
por: Luvisetto, Siro, et al.
Publicado: (2015) -
17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice
por: Vacca, Valentina, et al.
Publicado: (2016)